Payment overview · 2025
General Payments
$386.85
14 reported records · 3 companies
Healthcare provider profile · identity verified
Jung Lack Lee, MD
Allopathic & Osteopathic Physicians|Surgery · FLUSHING, NY · NPI 1457394306
Verified facts
What the public records show
CMS Open Payments records show Jung Lack Lee, MD received $386.85 in general payments during 2025 across 14 reported records.
Glaukos Corporation accounted for 46.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Linzess.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 1627 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 167 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Lumigan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Glaukos Corporation | Unresolved — no canonical attribution shown | $177.82 | 46.0% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $144.59 | 37.4% | 10 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $64.44 | 16.7% | 3 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $386.85 | 14 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| iDoseTR Normalized: idosetr |
Drug | Glaukos Corporation | $177.82 | 1 | 2025 |
Source payment records
|
|||||
| iStent Normalized: istent |
Device | Glaukos Corporation | $177.82 | 1 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $144.59 | 10 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $144.59 | 10 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $64.44 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 1627 | exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 167 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
1627 | 295 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
167 | 24 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Vascepa | Icosapent Ethyl | 3030 | 453 |
| Diclofenac Epolamine | Diclofenac Epolamine | 2020 | 267 |
| Celecoxib | Celecoxib | 1877 | 279 |
| Gabapentin | Gabapentin | 1690 | 259 |
| Omeprazole | Omeprazole | 1638 | 277 |
| Creon | Lipase/Protease/Amylase | 1627 | 295 |
| Meclizine Hcl | Meclizine Hcl | 1579 | 283 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1473 | 249 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 1448 | 210 |
| Amlodipine Besylate | Amlodipine Besylate | 1367 | 195 |
| Sertraline Hcl | Sertraline Hcl | 1316 | 222 |
| Donepezil Hcl | Donepezil Hcl | 1208 | 180 |
| Meloxicam | Meloxicam | 1073 | 191 |
| Losartan Potassium | Losartan Potassium | 923 | 143 |
| Tamsulosin Hcl | Tamsulosin Hcl | 841 | 118 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 784 | 155 |
| Restasis | Cyclosporine | 752 | 134 |
| Dexlansoprazole Dr | Dexlansoprazole | 728 | 111 |
| Montelukast Sodium | Montelukast Sodium | 715 | 118 |
| Alendronate Sodium | Alendronate Sodium | 710 | 149 |
| Ammonium Lactate | Ammonium Lactate | 690 | 106 |
| Simvastatin | Simvastatin | 681 | 100 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 655 | 92 |
| Myrbetriq | Mirabegron | 602 | 101 |
| Metformin Hcl | Metformin Hcl | 593 | 92 |
| Levothyroxine Sodium | Levothyroxine Sodium | 499 | 79 |
| Metoprolol Succinate | Metoprolol Succinate | 494 | 66 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 437 | 67 |
| Fluticasone Propionate | Fluticasone Propionate | 414 | 68 |
| Finasteride | Finasteride | 404 | 58 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 395 | 76 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 385 | 47 |
| Azelastine Hcl | Azelastine Hcl | 373 | 59 |
| Mirtazapine | Mirtazapine | 348 | 54 |
| Furosemide | Furosemide | 334 | 50 |
| Naproxen | Naproxen | 331 | 62 |
| Clopidogrel | Clopidogrel Bisulfate | 310 | 46 |
| Zenpep | Lipase/Protease/Amylase | 287 | 44 |
| Ciclopirox | Ciclopirox Olamine | 260 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 253 | 78 |
| Trazodone Hcl | Trazodone Hcl | 248 | 33 |
| Fenofibrate | Fenofibrate Nanocrystallized | 246 | 39 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 243 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 237 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 237 | 30 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 229 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 216 | 30 |
| Carvedilol | Carvedilol | 212 | 31 |
| Lisinopril | Lisinopril | 202 | 32 |
| Levofloxacin | Levofloxacin | 191 | 152 |
| Memantine Hcl Er | Memantine Hcl | 191 | 32 |
| Pantoprazole Sodium | Pantoprazole Sodium | 184 | 30 |
| Prolia | Denosumab | 184 | 109 |
| Januvia | Sitagliptin Phosphate | 179 | 27 |
| Glimepiride | Glimepiride | 176 | 28 |
| Linzess | Linaclotide | 167 | 24 |
| Mometasone Furoate | Mometasone Furoate | 163 | 22 |
| Cephalexin | Cephalexin | 156 | 110 |
| Ibuprofen | Ibuprofen | 153 | 38 |
| Azithromycin | Azithromycin | 152 | 120 |
| Metformin Hcl Er | Metformin Hcl | 148 | 22 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 144 | 45 |
| Halobetasol Propionate | Halobetasol Propionate | 128 | 19 |
| Eliquis | Apixaban | 126 | 20 |
| Famotidine | Famotidine | 125 | 18 |
| Ketoconazole | Ketoconazole | 123 | 16 |
| Dexilant | Dexlansoprazole | 117 | 33 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 116 | 37 |
| Allopurinol | Allopurinol | 116 | 18 |
| Trintellix | Vortioxetine Hydrobromide | 115 | 15 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 110 | 13 |
| Raloxifene Hcl | Raloxifene Hcl | 110 | 20 |
| Nebivolol Hcl | Nebivolol Hcl | 108 | 12 |
| Atenolol | Atenolol | 105 | 19 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 103 | 16 |
| Clotrimazole | Clotrimazole | 101 | 19 |
| Clobetasol Propionate | Clobetasol Propionate | 98 | 24 |
| Lidocaine | Lidocaine | 90 | 15 |
| Icosapent Ethyl | Icosapent Ethyl | 85 | 24 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 82 | 14 |
| Methylprednisolone | Methylprednisolone | 82 | 68 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 81 | 17 |
| Symbicort | Budesonide/Formoterol Fumarate | 81 | 19 |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | suppressed |
| Dutasteride | Dutasteride | 73 | suppressed |
| Jardiance | Empagliflozin | 73 | 11 |
| Loperamide | Loperamide Hcl | 73 | 53 |
| Ozempic | Semaglutide | 73 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 73 | 12 |
| Glipizide Er | Glipizide | 70 | suppressed |
| Tradjenta | Linagliptin | 70 | suppressed |
| Metoprolol Tartrate | Metoprolol Tartrate | 69 | 14 |
| Ibandronate Sodium | Ibandronate Sodium | 68 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 65 | 19 |
| Fluocinonide | Fluocinonide | 65 | 11 |
| Xarelto | Rivaroxaban | 65 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 61 | 14 |
| Potassium Chloride | Potassium Chloride | 61 | suppressed |
| Cyclosporine | Cyclosporine | 59 | 26 |
| Farxiga | Dapagliflozin Propanediol | 59 | suppressed |
| Metronidazole | Metronidazole | 59 | 47 |
| Trulicity | Dulaglutide | 57 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 55 | 18 |
| Enalapril Maleate | Enalapril Maleate | 53 | suppressed |
| Latanoprost | Latanoprost | 53 | 11 |
| Colesevelam Hcl | Colesevelam Hcl | 52 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 52 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 51 | suppressed |
| Lubiprostone | Lubiprostone | 51 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 49 | 12 |
| Nitroglycerin | Nitroglycerin | 48 | 13 |
| Chlorthalidone | Chlorthalidone | 47 | suppressed |
| Lansoprazole | Lansoprazole | 46 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 45 | suppressed |
| Telmisartan | Telmisartan | 45 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 44 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 43 | 11 |
| Clonidine Hcl | Clonidine Hcl | 42 | suppressed |
| Ciclopirox | Ciclopirox | 41 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 41 | 35 |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 40 | suppressed |
| Colchicine | Colchicine | 39 | suppressed |
| Acyclovir | Acyclovir | 38 | 19 |
| Hydrocortisone | Hydrocortisone | 37 | suppressed |
| Nifedipine Er | Nifedipine | 37 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | suppressed |
| Procto-Med Hc | Hydrocortisone | 35 | 17 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 34 | suppressed |
| Memantine Hcl | Memantine Hcl | 34 | suppressed |
| Amoxicillin | Amoxicillin | 33 | 25 |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 33 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 32 | suppressed |
| Lactulose | Lactulose | 32 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 30 | suppressed |
| Proctozone-Hc | Hydrocortisone | 30 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Pregabalin | Pregabalin | 29 | suppressed |
| Bepotastine Besilate | Bepotastine Besilate | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 11 |
| True Comfort Alcohol Pads | Alcohol Antiseptic Pads | 27 | suppressed |
| Cilostazol | Cilostazol | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Fenofibrate | Fenofibrate | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | 20 |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Valsartan | Valsartan | 25 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 25 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 18 |
| Vemlidy | Tenofovir Alafenamide | 24 | suppressed |
| Baclofen | Baclofen | 23 | 11 |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Roflumilast | Roflumilast | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Diflorasone Diacetate | Diflorasone Diacetate | 22 | suppressed |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 22 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 22 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 16 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Omeprazole-Sodium Bicarbonate | Omeprazole/Sodium Bicarbonate | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | 12 |
| Flecainide Acetate | Flecainide Acetate | 18 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 18 | suppressed |
| Travoprost | Travoprost | 18 | suppressed |
| Ursodiol | Ursodiol | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 17 | suppressed |
| Entecavir | Entecavir | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Pentoxifylline | Pentoxifylline | 16 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 16 | suppressed |
| Glipizide Xl | Glipizide | 15 | suppressed |
| Letrozole | Letrozole | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Mupirocin | Mupirocin | 15 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 14 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 12 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 12 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Advocate Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Pimecrolimus | Pimecrolimus | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $386.85 · 14 records | Glaukos Corporation | CREON, LINZESS, VOQUEZNA, iDoseTR, iStent | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error